Highlights of articles published in annals of nuclear medicine 2016
- 546 Downloads
This article is the first installment of highlights of selected articles published during 2016 in the Annals of Nuclear Medicine, an official peer-reviewed journal of the Japanese Society of Nuclear Medicine. A companion article highlighting selected articles published during 2016 in the European Journal of Nuclear Medicine and Molecular Imaging, which is the official peer-reviewed journal of the European Association of Nuclear Medicine, will also appear in the Annals Nuclear Medicine. This new initiative by the respective journals will continue as an annual endeavor and is anticipated to not only enhance the scientific collaboration between Europe and Japan but also facilitate global partnership in the field of nuclear medicine and molecular imaging.
KeywordsTSPO 99mTc-TRODAT-1 123I–BMIPP Anti-18F-FACBC 68Ga-DOTA-TRP PET/CT PET/MR Radioembolization Systematic review Meta-analysis Choline
Compliance with ethical standards
National Institutes of Health grants R01-CA111613, R21-CA142426, R21-EB017568, and P30-CA014089 supported this article.
Conflict of interest
The author declares that he has no conflict of interest.
This article does not contain any studies with human participants or animals performed by the author.
- 21.FDA approves new diagnostic imaging agent to detect recurrent prostate cancer. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm503920.htm. Accessed 1 July 2017.
- 51.Roach M 3rd, Hanks G, Thames H Jr, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO phoenix consensus conference. Int J Radiat Oncol Biol Phys. 2006;65:965–74.CrossRefPubMedGoogle Scholar
- 58.Buchegger F, Garibotto V, Zilli T, et al. First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy. Eur J Nucl Med Mol Imaging. 2014;41:68–78.CrossRefPubMedGoogle Scholar
- 59.Watanabe H, Ishii K, Hosono M, et al. Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan. Ann Nucl Med. 2016;30:433–44.Google Scholar